Biobanks can collect and preserve biological samples and resources for genomics, proteomics, and customized drug development research and future usage by patients.
Avantor, BioCision, Biovault Family, Hamilton Company, Lonza, Merck KGaA, PromoCell GmbH, Stemcell technologies, Tecan Trading, and Thermo Fisher Scientific are leading the biobanks market in terms of share and revenue.
Companies utilize competitive strategies like R&D, market rank analysis, market capitalization, etc, in order to increase their market share in the biobanking sector.
The global biobanks market size was estimated to be $65 BN in 2021.
The global market for biobanks will most likely expand at over 4.5% CAGR through 2023 to 2032.
A scientist may also get access to a large amount of genomic data for research purposes. This along with the large-scale adoption of biotechnological services has increased the demand for the global biobanks market.
Copyright © 2024 Same Page Management Consulting Pvt. Ltd. (insightSLICE) | All Rights Reserved